TP53 and neoplasm: With frequent alterations in main driver genes, including KRAS, TP53, CDKN2A, and SMAD4, Moffitt et al. (2015) and Bailey et al. (2016) established the molecular subtypes of PDAC, which showed the difference in survival according to tumor biology [7–9].